Mostrar el registro sencillo del ítem
Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder
dc.creator | Fernández-Guasti, A. | |
dc.creator | Ulloa, R.E. | |
dc.creator | Nicolini, H. | |
dc.date.accessioned | 2017-06-29T04:31:03Z | |
dc.date.available | 2017-06-29T04:31:03Z | |
dc.date.issued | 2003 | es_ES |
dc.identifier | 404 | es_ES |
dc.identifier.issn | 0033-3158 | es_ES |
dc.identifier.uri | http://repositorio.inprf.gob.mx/handle/123456789/5095 | |
dc.identifier.uri | https://doi.org/10.1007/s00213-002-1301-1 | es_ES |
dc.language.iso | eng | es_ES |
dc.relation | 166 (3) 195-201 p. | es_ES |
dc.relation | versión del editor | es_ES |
dc.rights | acceso cerrado | es_ES |
dc.subject.mesh | 8-Hydroxy-2-(di-n-propylamino)tetralin | es_ES |
dc.subject.mesh | Aging-Psychology | es_ES |
dc.subject.mesh | Animals | es_ES |
dc.subject.mesh | Antidepressive Agents, Tricyclic-Therapeutic use | es_ES |
dc.subject.mesh | Desipramine-Pharmacology | es_ES |
dc.subject.mesh | Dose-Response Relationship, Drug | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Obsessive Compulsive Disorder-Drug therapy | es_ES |
dc.subject.mesh | Piperazines | es_ES |
dc.subject.mesh | Pyridines | es_ES |
dc.subject.mesh | Rats | es_ES |
dc.subject.mesh | Rats, Wistar | es_ES |
dc.subject.mesh | Receptors, Serotonin-Drug effects | es_ES |
dc.subject.mesh | Receptors, Serotonin, 5-HT1 | es_ES |
dc.subject.mesh | Serotonin Antagonists | es_ES |
dc.subject.mesh | Serotonin Receptor Agonists | es_ES |
dc.subject.mesh | Receptors, Serotonin | es_ES |
dc.subject.mesh | Serotonin Antagonists | es_ES |
dc.subject.mesh | Clomipramine | es_ES |
dc.subject.mesh | N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide | es_ES |
dc.subject.mesh | 8-Hydroxy-2-(di-n-propylamino)tetralin | es_ES |
dc.title | Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder | es_ES |
dc.type | article | es_ES |
dc.contributor.affiliation | Departamento de Farmacobiología, Centro de Investigación y Estudios Avanzados, Calz. De los Tenorios 235, Col. Granjas Coapa, 14330, México D.F., México | es_ES |
dc.contributor.email | jfernand@mail.cinvestav.mx | es_ES |
dc.relation.jnabreviado | PSYCHOPHARMACOLOGY | es_ES |
dc.relation.journal | Psychopharmacology | es_ES |
dc.identifier.place | Alemania | es_ES |
dc.date.published | 2003 | es_ES |
dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
dc.identifier.eissn | 1432-2072 | es_ES |
dc.identifier.doi | 10.1007/s00213-002-1301-1 | es_ES |
dc.description.month | Mar | es_ES |
dc.description.abstractotrodioma | RATIONALE: Subtypes of obsessive-compulsive disorder (OCD) related to age could determine differential response to treatment.OBJECTIVES: To explore possible age differences in the effect of clomipramine in an animal model of OCD. METHODS: The deficits on spontaneous alternation produced by 8-OH-DPAT and the preventing actions of clomipramine, desipramine and WAY 100635 were compared between young and adult rats. RESULTS: No age differences were found in spontaneous alternation. The 5-HT(1A) agonist, 8-OH-DPAT (0.031, 0.125, 0.5 and 2.0 mg-kg, -15 min) produced perseveration in young and adult rats. However, young rats were sensitive to a lower dose of 8-OH-DPAT. Clomipramine (10 mg-kg per three administrations) completely prevented the action of 8-OH-DPAT (0.5 mg-kg) in adult rats. However, this treatment as well as higher doses (15 mg-kg 3 administrations) or injected for longer periods (10 mg-kg 5 administrations) produced weak protective effects (versus 0.125 mg-kg 8-OH-DPAT) or had no action (versus 0.5 mg-kg 8-OH-DPAT) in young animals. WAY 100 635 (0.5 mg-kg) blocked the action of 8-OH-DPAT (0.5 mg-kg) in both young and adult rats. Desipramine (10 mg-kg-3 administrations) lacked of a preventive effect on the 8-OH-DPAT (0.5 mg-kg) action. This result indicated that the 5-HT(1A) receptor is involved in the deficits on spontaneous alternation produced by 8-OH-DPAT. CONCLUSIONS: The present data shows important age differences in the effect of clomipramine in a model of OCD. Such differences could be relevant for the age variations in the response to treatment in clinical practice | es_ES |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |